Patents/Assignees

ABLYNX NV

3 patents in portfolio

US12209136utility2025
ADAMTS Binding Immunoglobulins
0 cites
US12129308utility2024
MMP13 Binding Immunoglobulins
0 cites
US11813307utility2023
Polypeptides Binding ADAMTS5, MMP13 and Aggrecan
0 cites